Using PBPK Modeling for Risk Assessment in Drug Product Development

preview_player
Показать описание
Using PBPK Modeling for Risk Assessment in Drug Product Development

Siddharth S. Kesharwani, PhD
Biopharmaceutics Scientist
Sanofi
  1. Uber Events
Рекомендации по теме
Using PBPK Modeling 0:34:15

Using PBPK Modeling for Risk Assessment in Drug Product Development

Introduction to PBPK 0:34:35

Introduction to PBPK Modeling for Chemical Risk Assessment

PBPK Modeling for 1:03:02

PBPK Modeling for Identifying and Mitigating Absorption Risks in Early Drug Development

Human Exposure Predictions 1:37:38

Human Exposure Predictions and Food Effect Risk Identification Using PBPK Models

Applications of PBPK 0:59:17

Applications of PBPK modelling for regulatory submissions: case studies

Common Myths about 0:03:39

Common Myths about PBPK Modeling and Simulation- Busted!

A Best Practice 0:55:39

A Best Practice Framework for Applying PBPK Modeling to Pediatric Drug Development

Applications of GastroPlus 1:23:40

Applications of GastroPlus PBPK Modeling at the FDA Office of Generic Drugs

PBPK for the 0:58:36

PBPK for the Pill An approach to assess the risk benefit of drugs

PBPK based approach 0:27:50

PBPK based approach towards risk assessment

Using PBPK Absorption 0:15:48

Using PBPK Absorption Modeling to Support Biopharmaceutics Classification System Class 3 Drug Waiver

PBPK Modelling to 1:13:05

PBPK Modelling to Predict Salt Form Advantage when Dosed with Acid-Reducing Agents

PBPK Modeling and 0:50:49

PBPK Modeling and Simulation for Regulatory Decision Making: Impact on US Prescribing Information

A physiologically based 0:20:32

A physiologically based pharmacokinetic (PBPK) model of pravastatin

Physiologically Based Pharmacokinetic 0:59:39

Physiologically Based Pharmacokinetic Modelling for First‑In‑Human Predictions

Application of PBPK 0:57:41

Application of PBPK modeling & simulation to support dose selection in special populations

PBPK modeling supports 0:01:52

PBPK modeling supports approval of breakthrough cancer drug

Developing Compound Files 0:13:20

Developing Compound Files for PBPK Modeling in the Simcyp Simulator

A Physiologically Based 0:19:43

A Physiologically Based Pharmacokinetic Model to Predict the Superparamagnetic Iron Oxide...

Strategic Application of 0:59:17

Strategic Application of PBPK Models for Predicting DDIs & the Effects of Smoking & Organ Im...

IVIVE-PBPK Modeling for 0:19:14

IVIVE-PBPK Modeling for Inhalation Toxicity Testing

De-risk pre-IND stage 0:54:19

De-risk pre-IND stage decisions with Simcyp Discovery PBPK software

Applying MAM PBPK 1:28:00

Applying MAM PBPK Modeling to Predict Positive Negative Food Effects

Application of Physiologically-based 1:05:52

Application of Physiologically-based Pharmacokinetics (PBPK) to Personalized Dosing